查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836769

非处方药市场（按疾病/病症类型、配方类型、产品类型和分销管道划分）—2025-2032 年全球预测

Over-The-Counter Consumer Health Products Market by Disease/Disorder Type, Formulation Type, Product Category, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年非处方药市场规模将成长至 3,777.7 亿美元，复合年增长率为 6.95%。

主要市场统计数据
基准年2024年 2205.2亿美元
预计2025年 2351.6亿美元
预测年份：2032年 3777.7亿美元
复合年增长率（%） 6.95%

快速变化的消费者期望、监管审查和通路动态为重新定义 OTC 消费者卫生领域奠定了基础

随着消费者预期、分销模式和法规环境的融合，非处方药 (OTC) 产业正在加速发展，重塑非处方药的开发、行销和消费方式。本导言将读者置于这样一个环境中：可近性、实证产品标籤和产品便利性是竞争定位的核心。数位化消费行为的兴起正在改变人们发现和评估产品的方式，线上管道影响着产品的发现、信任的建立和重复购买。

配方和包装创新正在满足日益增长的差异化体验和更高依从性的需求，而零售和医疗管道也在不断适应便利模式和临床整合。同时，供应商网路和筹资策略也更加重视弹性、透明度和成本效益。这些动态发生在监管审查和公共卫生优先事项不断演变的背景下，这些优先事项强调安全性、标籤清晰性和已证实的益处。

本介绍为后续分析设定了框架：变革性转变如何在治疗和产品类型中体现，政策变化如何与供应链交叉，细分和区域动态如何定义策略机会等。透过这个视角，后续章节将为产品开发、商业策略和业务规划提供实际意义。

数位转型、配方突破、全通路零售以及不断提高的监管预期如何从根本上重塑非处方药领域的竞争动态

在消费行为、技术创新以及安全和循证法规等诸多因素的共同推动下，该行业正在经历一场变革性转变。数位健康生态系统正在显着改变病人历程，加速那些已证实便捷且临床益处公认的产品的采用週期。因此，製造商正在优先考虑数位行销策略、直销管道以及数据主导的洞察，以优化目标定位并衡量疗效。

同时，配方创新正在拓展给药机制的选择，从用于缓释性的经皮製剂到改善口服补充剂口感和稳定性的微胶囊技术。这些进步为解决依从性、增强行销以及透过配方改善延长产品生命週期创造了新的机会。电商、零售药局和量贩店之间的全通路整合创造了无缝的购买路径，而自有品牌计画和零售商自有品牌则加剧了竞争。

监管和公共卫生情况正在同步演变，人们越来越重视标籤透明度、健康声明的证据标准以及上市后的安全监测。这些变化要求製造商和通路合作伙伴调整其产品开发、证据产生和打入市场策略，以在快速变化的环境中保持相关性和韧性。

评估关税变化对整个非处方药产品价值链的采购、製造弹性和商业定价策略的持续影响

近期的关税措施和贸易政策调整对非处方药的采购、生产和定价策略产生了累积影响，迫使相关人员重新评估其供应链配置和成本曝险。原料和包装零件的进口关税正在增强企业多元化供应商基础、尽可能加快在地采购以及垂直整合关键製造流程的奖励。因此，采购团队正在仔细审查物料清单的敏感性，并寻找能够减少运输时间和关税负担的替代化学品和本地供应商。

同时，製造商正在评估减少对进口中间体依赖的配方路线，包括探索本地契约製造和双源采购模式。这种转变正在影响产品的优先排序，企业推迟推出需要复杂进口原料的非核心产品，同时加快开发对关税较不敏感的产品。一些公司正在消化暂时的成本上涨以维持其市场地位，而另一些公司则透过提高成本驱动因素的透明度来进行有针对性的价格调整。

产业、监管和政策反应持续影响营运选择，促使企业进行供应链压力测试并制定应急计画。领导者务必将关税风险视为持久的策略变量，而非短期干扰，这将影响采购、库存政策和产品系列决策。

深度細項分析揭示了治疗重点、配方选择、产品类型和分销管道如何影响产品策略和竞争定位

细緻的细分视角揭示了不同治疗重点领域、配方选择、产品类型和分销管道中差异化的需求驱动因素和营运重点。我们根据疾病/病症类型，研究了过敏管理、心血管健康、慢性疼痛、糖尿病管理、心理健康和保健以及骨质疏鬆症市场，揭示了影响产品设计和促销的不同证据要求、季节性和患者依从性考虑因素。我们根据剂型，研究了凝胶/液体、贴片/经皮、粉剂和片剂/胶囊，每种剂型的製造复杂性、稳定性和使用者偏好动态各不相同，这些因素会影响成本结构和行销方案。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 基于数据驱动的健康资讯的个人化免疫补充剂需求不断增长
  • 旨在缓解压力和改善睡眠的 CBD 健康产品的兴起
  • 含有经临床验证的益生菌菌株的肠道菌丛支持补充剂激增
  • 结合天然适应原和植物成分的女性荷尔蒙平衡补充剂市场快速成长
  • 消费者对透明补充剂标籤检视和第三方功效测试的偏好日益增长
  • 实施数位健康工具和应用程式来追踪和优化非处方药的依从性和结果
  • 环保和永续包装解决方案的出现，减少了塑胶并支持循环经济

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 非处方药市场（依疾病/病症类型）

  • 过敏管理
  • 心血管健康
  • 慢性疼痛
  • 糖尿病管理
  • 心理健康与保健
  • 骨质疏鬆症

9. 非处方药市场（依处方类型）

  • 凝胶和液体
  • 贴片和经皮
  • 粉末
  • 片剂和胶囊

第十章非处方药市场（产品类型）

  • 过敏药物
  • 止痛药（缓解疼痛）
  • 咳嗽、感冒和流感药物
  • 皮肤科产品
  • 眼部护理
  • 女性卫生与健康
  • 胃肠药
  • 口腔健康
  • 助眠剂
  • 维生素和营养补充剂
  • 体重管理和营养

第 11 章非处方药市场（依分销管道）

  • 医院和诊所
  • 大卖场和超级市场
  • 零售药局

第十二章 OTC药品市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章非处方药市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国药品市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • 3M Company
    • Abbott Laboratories
    • Amway Corporation
    • Archer Daniels Midland Company
    • B. Braun SE
    • Bayer AG
    • Beiersdorf AG
    • Boehringer Ingelheim GmbH
    • Cardinal Health, Inc.
    • Cipla Limited
    • Cosmetic Skin Solutions, LLC
    • Dr. Reddy's Laboratories
    • Essity AB
    • Estee Lauder Companies Inc.
    • FastFill Pack, Inc.
    • Glanbia PLC
    • GlaxoSmithKline PLC
    • Glenmark Pharmaceuticals Ltd.
    • InSpec Solutions, LLC
    • Integra Lifesciences Corporation
    • Johnson & Johnson services, Inc.
    • Koninklijke DSM NV
    • L'Oreal SE
    • Lonza Group Ltd.
    • Medline Industries, Inc.
    • Mineral Mine
    • Molnlycke Health Care AB
    • Nardo's Natural, Inc. by by Barbara Corcoran
    • Natures Formulae Ltd.
    • Nestle SA
    • Nichiban Co., Ltd.
    • Onoxa LLC
    • Paul Hartmann AG
    • Pfizer, Inc.
    • Piramal Enterprises Ltd.
    • Reckitt Benckiser LLC
    • Sanofi SA
    • Smith & Nephew PLC
    • Sun Pharmaceuticals Ltd.
Product Code: MRR-036C5CF3B4E6

The Over-The-Counter Consumer Health Products Market is projected to grow by USD 377.77 billion at a CAGR of 6.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 220.52 billion
Estimated Year [2025] USD 235.16 billion
Forecast Year [2032] USD 377.77 billion
CAGR (%) 6.95%

Setting the scene for rapidly shifting consumer expectations, regulatory scrutiny, and channel dynamics that are redefining the OTC consumer health landscape

The over-the-counter consumer health sector is undergoing accelerated evolution as consumer expectations, distribution models, and regulatory environments converge to reshape how OTC products are developed, marketed, and consumed. This introduction situates the reader within a landscape where accessibility, evidence-driven product claims, and product convenience are increasingly central to competitive positioning. The proliferation of digitally enabled consumer journeys has changed how products are discovered and evaluated, with online channels exerting influence across discovery, trust-building, and repeat purchase.

Innovation in formulations and packaging is responding to heightened demand for differentiated experiences and improved adherence, while retail and institutional channels adapt to both convenience-driven models and clinical integration. At the same time, supplier networks and procurement strategies are prioritizing resilience, transparency, and cost-efficiency. These dynamics are occurring against a backdrop of evolving regulatory scrutiny and public health priorities that emphasize safety, labeling clarity, and substantiation of benefits.

This introduction establishes the framework for the deeper analyses that follow: how transformational shifts manifest across therapeutic and product categories, how policy changes intersect with supply chains, and how segmentation and regional dynamics define strategic opportunity. Through this lens, the subsequent sections map practical implications for product development, commercial strategy, and operational planning.

How digital transformation, formulation breakthroughs, omnichannel retailing, and heightened regulatory expectations are fundamentally reshaping competitive dynamics in OTC care

The sector is experiencing transformative shifts driven by converging forces of consumer behavior, technological innovation, and regulatory emphasis on safety and evidence. Digital health ecosystems have significantly altered patient and customer journeys, enabling faster adoption cycles for products that offer demonstrable convenience and perceived clinical benefit. As a result, manufacturers are prioritizing digitally enabled marketing strategies, direct-to-consumer channels, and data-driven insights to sharpen targeting and measure outcomes.

Simultaneously, formulation innovation is broadening the palette of delivery mechanisms, from transdermal solutions designed for sustained release to microencapsulation techniques that improve taste and stability in oral supplements. These advances create new opportunities to address adherence and to extend product lifecycles through reformulation rather than incremental marketing alone. Retail models are also shifting: omnichannel integration between e-commerce, retail pharmacies, and mass merchandisers is creating seamless purchasing pathways, while private-label programs and retailer-owned brands are intensifying competitive dynamics.

Regulatory and public-health narratives are evolving in parallel, with greater attention to labeling transparency, evidence standards for health claims, and post-market safety monitoring. Taken together, these shifts demand that manufacturers and channel partners align product development, evidence generation, and go-to-market strategies to remain relevant and resilient in a rapidly changing environment.

Assessing the sustained reverberations of tariff shifts on sourcing, manufacturing resilience, and commercial pricing strategies throughout the OTC product value chain

Recent tariff measures and trade policy adjustments have exerted cumulative effects across sourcing, manufacturing, and pricing strategies for consumer health products, leading stakeholders to reassess supply-chain configurations and cost-exposure profiles. Import duties on raw materials and packaging components have reinforced incentives to diversify supplier bases, accelerate local sourcing where feasible, and to vertically integrate key manufacturing steps. Consequently, procurement teams are scrutinizing bill-of-materials sensitivity, seeking alternative chemistries and regional suppliers that reduce transit time and tariff liability.

In parallel, manufacturers are evaluating formulation pathways that reduce dependency on imported intermediates, including exploring local contract manufacturing and dual-sourcing models. These shifts are affecting product prioritization, with organizations more likely to delay non-core launches that require complex imported inputs while accelerating iterations on products that are less tariff-sensitive. Pricing strategies are being revisited in context; some firms are absorbing incremental costs temporarily to preserve market positioning, while others are implementing targeted price adjustments communicated through greater transparency on cost drivers.

Policy responses from industry and regulators continue to shape operational choices, prompting supply-chain stress tests and contingency planning. For leaders, the key takeaway is to treat tariff exposure as a persistent strategic variable that influences sourcing, inventory policies, and product portfolio decisions rather than as a short-term disruption.

Deep segmentation analysis revealing how therapeutic focus, formulation choice, product category, and distribution channel collectively shape product strategy and competitive positioning

A granular segmentation lens reveals differentiated demand drivers and operational priorities across therapeutic focus, formulation choices, product categories, and distribution channels. Based on Disease/Disorder Type, the market is studied across Allergy Management, Cardiovascular Health, Chronic Pain, Diabetes Management, Mental Health and Wellness, and Osteoporosis, which highlights varied evidence requirements, seasonality, and patient adherence considerations that influence product design and promotion. Based on Formulation Type, the market is studied across Gels & Liquids, Patch & Transdermal, Powders, and Tablets & Capsules, indicating divergent manufacturing complexity, stability profiles, and user-preference dynamics that affect cost structures and marketing narratives.

Based on Product Category, the market is studied across Allergy Medications, Analgesics (Pain Relief), Cough, Cold & Flu Remedies, Dermatological Products, Eye Care, Feminine Hygiene and Health, Gastrointestinal Products, Oral Health, Sleep Aids, Vitamins & Dietary Supplements, and Weight Management & Nutrition, revealing distinct regulatory pathways, claim substantiveness, and competitive intensity across categories. Based on Distribution Channel, the market is studied across Hospital & Clinics, Hypermarkets & Supermarkets, and Retail Pharmacies, underscoring how clinical endorsement, shelf placement, and retail promotions differentially impact access and consumer trust.

Integrating these segmentation dimensions enables a nuanced view of prioritization: therapeutic categories with high clinical touchpoints demand stronger evidence and clinical partnerships; formulation innovation unlocks differentiation in crowded categories; and distribution strategies must be tailored to the intersection of product type and consumer expectations to maximize uptake and perceived value.

Regional strategies that reconcile diverse consumer behaviors, regulatory regimes, and distribution architectures across Americas, EMEA, and Asia-Pacific to optimize market approaches

Regional dynamics shape product preferences, regulatory approaches, and distribution structures, creating distinct strategic considerations across major geographies. In the Americas, consumer expectations emphasize convenience, value, and a growing appetite for clinically substantiated self-care solutions, while retail pharmacy chains and large mass merchandisers exert strong influence over assortment, pricing, and private-label development. In Europe, Middle East & Africa, regulatory heterogeneity and varied payer models require adaptable labeling, multilingual packaging, and flexible distribution partnerships, with demand profiles that range from clinically oriented OTC products to culturally specific remedial solutions.

In Asia-Pacific, rapid urbanization, expanding middle-class cohorts, and digital-first shopping behaviors are accelerating adoption of innovative formulations and branded supplements, while local manufacturing hubs and diversified supplier networks offer opportunities for cost optimization. Across all regions, cross-border e-commerce is further eroding traditional geographic boundaries, enabling brands to test new markets quickly but also exposing them to disparate regulatory and customs requirements.

Strategic leaders should tailor market entry and expansion plans to regional norms: prioritize clinical evidence and pharmacy channel alliances in some regions, emphasize cost-competitive sourcing and digital reach in others, and ensure regulatory readiness for local label and safety requirements to avoid delays and market access friction.

Competitive imperatives for manufacturers: balancing scale, formulation innovation, omnichannel commercialization, and supply-chain transparency to capture sustainable advantage

Competitive dynamics in the consumer health space are characterized by a mix of established multinational manufacturers, agile regional players, and entrepreneurial startups that specialize in niche formulations or direct-to-consumer models. Incumbents leverage scale advantages in manufacturing, regulatory expertise, and distribution relationships, but face pressure from nimble challengers that capitalize on faster innovation cycles, digital marketing sophistication, and targeted value propositions. Partnerships and strategic alliances-spanning contract manufacturers, ingredient specialists, and digital health platforms-have become common mechanisms to accelerate time-to-market while managing capital intensity and operational risk.

Investment in proprietary formulation technology, clinical evidence generation, and supply-chain transparency is increasingly material to competitive differentiation. Companies that demonstrate clear quality controls and traceability across raw-material supply chains earn greater trust among retailers and informed consumers. Moreover, the ability to operationalize omnichannel commerce, integrating pharmacy fulfillment with direct-to-consumer subscriptions and telehealth referrals, distinguishes organizations that can convert awareness into sustained loyalty.

Mergers and acquisitions continue to be a strategic lever for portfolio expansion and capability acquisition, but successful consolidation requires rigorous integration of R&D pipelines, regulatory practices, and commercial teams. Ultimately, companies that balance scale with customer-centric innovation and resilient supply chains are best positioned to capture long-term value.

Actionable steps for leaders to build supply-chain resilience, accelerate formulation and clinical differentiation, and master omnichannel commercialization for lasting advantage

Industry leaders should adopt a set of pragmatic, actionable steps to strengthen resilience, accelerate innovation, and capture consumer trust across the OTC ecosystem. First, prioritize reformulation and packaging innovations that improve adherence and convenience while simplifying manufacturing processes to reduce tariff and import sensitivity. Second, invest in robust clinical evidence and claim substantiation tailored to each therapeutic focus, pairing clinical data with digital engagement to build credibility and retention. Third, diversify supply chains by establishing regional suppliers and dual-sourcing strategies, complemented by inventory and procurement practices that mitigate disruption risk and cost volatility.

Leverage omnichannel go-to-market playbooks that integrate retail pharmacy partnerships with e-commerce, subscription models, and telehealth referral pathways to deepen consumer relationships. Enhance data capabilities to enable more precise segmentation and personalized messaging, using real-world evidence to refine product positioning and post-market surveillance. Additionally, evaluate partnerships and M&A opportunities selectively to acquire complementary capabilities such as advanced formulation platforms, proprietary ingredient access, or established direct-to-consumer audiences.

Finally, adopt transparent labeling and sustainability practices that resonate with increasingly informed consumers, and align regulatory engagement early in the product lifecycle to expedite approvals and reduce time-to-shelf. These steps, executed deliberately, will convert current challenges into durable competitive advantage.

Methodology overview describing interviews, secondary regulatory and clinical evidence synthesis, segmentation mapping, and supply-chain impact assessments used to derive practical insights

The research underpinning this executive summary combines a multi-method approach designed to deliver rigorous, practitioner-oriented insights. Primary inputs include structured interviews with industry stakeholders across manufacturing, retail, clinical practice, and procurement, supplemented by expert consultations that probe real-world operational and regulatory challenges. Secondary analysis synthesized publicly available regulatory guidance, clinical literature, and patent filings to contextualize formulation trends and evidence requirements.

Operationally, the methodology applied cross-sectional segmentation mapping to reconcile product categories, formulation types, therapeutic focus, and distribution pathways, enabling nuanced scenario analysis for strategy implications. Supply-chain impact assessments incorporated tariff exposures, sourcing concentrations, and lead-time variability to evaluate resilience and identify mitigation levers. Where appropriate, case studies of successful product innovations and channel shifts were used to illustrate best practices and common pitfalls.

Quality controls included triangulation of qualitative inputs with documented regulatory positions and supplier disclosures, and iterative validation with domain experts to ensure that interpretations reflect current industry realities. This methodological combination balances depth with practical relevance and is designed to support decision-making across commercial, regulatory, and operational functions.

Synthesis and strategic conclusions that prioritize integrated innovation, evidence-driven claims, and resilient sourcing to secure long-term competitive positioning in OTC care

The concluding synthesis emphasizes that success in the contemporary over-the-counter consumer health arena depends on coordinated action across product innovation, evidence generation, and distribution strategy. Consumer preferences are shifting toward convenient, clinically credible solutions delivered through seamless omnichannel experiences, while policy and tariff dynamics require proactive supply-chain strategies. Organizations that integrate formulation innovation with robust evidence and flexible sourcing are better equipped to navigate pricing pressures and regulatory scrutiny.

Moreover, the ability to move quickly-translating consumer intelligence into product iteration and channel activation-separates leaders from laggards. Strategic investments in data capabilities, partnerships, and regional supply networks create the operational bandwidth to pursue both short-term resilience and long-term growth. The imperative is clear: align R&D priorities with commercial realities, institutionalize evidence generation, and adopt diversified distribution and sourcing models that mitigate systemic risk.

Taken together, these conclusions provide a practical blueprint for executives tasked with stewarding portfolios, executing launches, or reconfiguring supply chains in response to evolving market and policy conditions. Intentional execution of these priorities will position organizations to capture sustained value in a dynamic sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for personalized immunity supplements powered by data driven health insights
  • 5.2. Proliferation of CBD based wellness products targeting stress relief and sleep improvement
  • 5.3. Surge in formulation of gut microbiome support supplements with clinically backed probiotic strains
  • 5.4. Rapid growth of female targeted hormonal balance supplements integrating natural adaptogens and botanicals
  • 5.5. Increasing consumer preference for transparent labeling and third party tested efficacy claims in supplements
  • 5.6. Adoption of digital health tools and apps to track and optimize over the counter medication adherence and outcomes
  • 5.7. Emergence of eco friendly and sustainable packaging solutions reducing plastic and supporting circular economy initiatives

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Over-The-Counter Consumer Health Products Market, by Disease/Disorder Type

  • 8.1. Allergy Management
  • 8.2. Cardiovascular Health
  • 8.3. Chronic Pain
  • 8.4. Diabetes Management
  • 8.5. Mental Health and Wellness
  • 8.6. Osteoporosis

9. Over-The-Counter Consumer Health Products Market, by Formulation Type

  • 9.1. Gels & Liquids
  • 9.2. Patch & Transdermal
  • 9.3. Powders
  • 9.4. Tablets & Capsules

10. Over-The-Counter Consumer Health Products Market, by Product Category

  • 10.1. Allergy Medications
  • 10.2. Analgesics (Pain Relief)
  • 10.3. Cough, Cold & Flu Remedies
  • 10.4. Dermatological Products
  • 10.5. Eye Care
  • 10.6. Feminine Hygiene and Health
  • 10.7. Gastrointestinal Products
  • 10.8. Oral Health
  • 10.9. Sleep Aids
  • 10.10. Vitamins & Dietary Supplements
  • 10.11. Weight Management & Nutrition

11. Over-The-Counter Consumer Health Products Market, by Distribution Channel

  • 11.1. Hospital & Clinics
  • 11.2. Hypermarkets & Supermarkets
  • 11.3. Retail Pharmacies

12. Over-The-Counter Consumer Health Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Over-The-Counter Consumer Health Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Over-The-Counter Consumer Health Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. 3M Company
    • 15.3.2. Abbott Laboratories
    • 15.3.3. Amway Corporation
    • 15.3.4. Archer Daniels Midland Company
    • 15.3.5. B. Braun SE
    • 15.3.6. Bayer AG
    • 15.3.7. Beiersdorf AG
    • 15.3.8. Boehringer Ingelheim GmbH
    • 15.3.9. Cardinal Health, Inc.
    • 15.3.10. Cipla Limited
    • 15.3.11. Cosmetic Skin Solutions, LLC
    • 15.3.12. Dr. Reddy's Laboratories
    • 15.3.13. Essity AB
    • 15.3.14. Estee Lauder Companies Inc.
    • 15.3.15. FastFill Pack, Inc.
    • 15.3.16. Glanbia PLC
    • 15.3.17. GlaxoSmithKline PLC
    • 15.3.18. Glenmark Pharmaceuticals Ltd.
    • 15.3.19. InSpec Solutions, LLC
    • 15.3.20. Integra Lifesciences Corporation
    • 15.3.21. Johnson & Johnson services, Inc.
    • 15.3.22. Koninklijke DSM N.V.
    • 15.3.23. L'Oreal SE
    • 15.3.24. Lonza Group Ltd.
    • 15.3.25. Medline Industries, Inc.
    • 15.3.26. Mineral Mine
    • 15.3.27. Molnlycke Health Care AB
    • 15.3.28. Nardo's Natural, Inc. by by Barbara Corcoran
    • 15.3.29. Natures Formulae Ltd.
    • 15.3.30. Nestle SA
    • 15.3.31. Nichiban Co., Ltd.
    • 15.3.32. Onoxa LLC
    • 15.3.33. Paul Hartmann AG
    • 15.3.34. Pfizer, Inc.
    • 15.3.35. Piramal Enterprises Ltd.
    • 15.3.36. Reckitt Benckiser LLC
    • 15.3.37. Sanofi S.A.
    • 15.3.38. Smith & Nephew PLC
    • 15.3.39. Sun Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CARDIOVASCULAR HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY MENTAL HEALTH AND WELLNESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GELS & LIQUIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PATCH & TRANSDERMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ALLERGY MEDICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ANALGESICS (PAIN RELIEF), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUGH, COLD & FLU REMEDIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DERMATOLOGICAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY EYE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FEMININE HYGIENE AND HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY ORAL HEALTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SLEEP AIDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY VITAMINS & DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY WEIGHT MANAGEMENT & NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HOSPITAL & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISEASE/DISORDER TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2018-2024 (USD MILLION)
  • TABLE 258. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY PRODUCT CATEGORY, 2025-2032 (USD MILLION)
  • TABLE 259. GCC OVER-THE-COUNTER CONSUMER HEALTH PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL,